as on October 25, 2025 at 1:29 am IST
Day's Low
Day's High
2.80%
Downside
1.11%
Upside
52 Week's Low
52 Week's High
83.71%
Downside
43.70%
Upside
Check Phathom Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$965.5M
EPS (TTM)
-2.6275
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-268.3M
Revenue (TTM)
114.0M
Profit Margin
-289.51%
Return On Equity TTM
-3489.00%
Compare market cap, revenue, PE, and other key metrics of Phathom Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $965.5M | -66.01% | NA | -289.51% | |
| BUY | $60.9B | 251.51% | -505.15 | -12.96% | |
| NA | $35.7B | NA | NA | -3.89% | |
| BUY | $109.3B | 99.16% | 30.04 | 31.86% | |
| BUY | $62.0B | -0.32% | 14.51 | 31.37% |
The Phathom Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Phathom Pharmaceuticals Inc investment value today
Current value as on today
₹89,155
Returns
Returns from Phathom Pharmaceuticals Inc Stock
Dollar Returns*
₹4,606 (+4.61%)
Based on 14 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 14 analysts, 85.71% of analysts recommend a 'BUY' rating for Phathom Pharmaceuticals Inc. Average target price of $21.38
Get share price movements and forecasts by analysts on Phathom Pharmaceuticals Inc.
What analysts predicted
36.53%UPSIDE
Target Price
$21.38
Current Price
$13.57
Analyzed by
14 Analysts
Target
$21.38
Phathom Pharmaceuticals Inc target price $21.38, a slight upside of 36.53% compared to current price of $13.57. According to 14 analysts rating.
Search interest for Phathom Pharmaceuticals Inc Stock has increased by 105% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:105% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 6 months, PHAT stock has moved up by 229.2%
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.7% return, outperforming this stock by 78.4%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 133.4% return, outperforming this stock by 104.4%
| Organisation | Phathom Pharmaceuticals Inc |
| Headquarters | 100 Campus Drive, Florham Park, NJ, United States, 07932 |
| Industry | Health Technology |
| CEO | Mr. Steven L. Basta M.B.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Steven L. Basta M.B.A. | CEO, President & Director |
Mr. Sanjeev Narula | Chief Financial & Business Officer |
Mr. Jonathan Bentley | Senior VP and Head of Sales, Operations & Training |
Mr. Robert Breedlove | VP of Finance & Principal Accounting Officer |
Mr. Eric Sciorilli | Director of Business Development & Investor Relations |
Mr. Bill Aprea J.D. | Senior VP, Chief Compliance Officer & Deputy Chief Legal Officer |
Mr. David A. Socks | Co-Founder |
Dr. Azmi Nabulsi M.D., M.P.H. | Co-Founder |
Ms. Anne Marie Cook Esq., J.D. | Chief Legal Officer & Corporate Secretary |
Mr. Paul Cocja | Chief People Officer |
Phathom Pharmaceuticals Inc share price today is $13.57 as on at the close of the market. Phathom Pharmaceuticals Inc share today touched a day high of $13.72 and a low of $13.19.
Phathom Pharmaceuticals Inc share touched a 52 week high of $19.5 on and a 52 week low of $2.21 on . Phathom Pharmaceuticals Inc stock price today i.e. is closed at $13.57,which is 30.41% down from its 52 week high and 514.03% up from its 52 week low.
Phathom Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Phathom Pharmaceuticals Inc (PHAT) shares with as little as ₹87.796 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹877.96 in Phathom Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Phathom Pharmaceuticals Inc share’s latest price of $13.57 as on October 25, 2025 at 1:29 am IST, you will get 0.7369 shares of Phathom Pharmaceuticals Inc. Learn more about
fractional shares .
Phathom Pharmaceuticals Inc stock has given -66.01% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?